← Back to Discover
Tri Locum Partners LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $813,224,117
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- JOHNSON & JOHNSON · COM · 478160104 · shares: $107,923,282
- VERTEX PHARMACEUTICALS INC · COM · 92532F100 · shares: $100,235,643
- ELI LILLY & CO · COM · 532457108 · shares: $91,794,777
- ASCENDIS PHARMA A/S · ORD SHS · K08588103 · shares: $69,011,133
- DEXCOM INC · COM · 252131107 · shares: $55,259,261
- AXSOME THERAPEUTICS INC. · COM · 05464T104 · shares: $53,680,019
- JAZZ PHARMACEUTICALS PLC · SHS USD · G50871105 · shares: $53,427,868
- ENLIVEN THERAPEUTICS INC · COM · 29337E102 · shares: $43,985,837
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $38,591,521
- MADRIGAL PHARMACEUTICALS INC · COM · 558868105 · shares: $36,659,187
Reported holdings
19 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | COM | 478160104 | — | 424,945 shares | $107,923,282 |
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | — | 201,791 shares | $100,235,643 |
| ELI LILLY & CO | COM | 532457108 | — | 76,532 shares | $91,794,777 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 258,740 shares | $69,011,133 |
| DEXCOM INC | COM | 252131107 | — | 820,479 shares | $55,259,261 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 219,308 shares | $53,680,019 |
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | — | 221,720 shares | $53,427,868 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 866,716 shares | $43,985,837 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 41,596 shares | $38,591,521 |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | — | 68,273 shares | $36,659,187 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 151,822 shares | $28,433,224 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 47,026 shares | $25,480,098 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | — | 746,835 shares | $25,302,770 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 328,340 shares | $20,665,720 |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | — | 47,983 shares | $19,081,879 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 194,000 shares | $16,526,860 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 120,712 shares | $11,767,006 |
| BETA BIONICS INC | COM | 08659B102 | — | 493,344 shares | $7,730,700 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 162,996 shares | $7,667,332 |